The validity of atypical depression in DSM-IV

Area of Science:

• Psychiatry
• Clinical Psychology
• Neuroscience

Background:

• Atypical depression is an episode specifier in the DSM-IV for major depressive episodes and dysthymia.
• Clinical validity of syndromes is established using operational criteria.
• Previous research has explored the diagnostic criteria and treatment responses for atypical depression.

Purpose of the Study:

• To review evidence for the clinical validity of atypical depression.
• To evaluate atypical depression against Kendall's six criteria for clinical syndrome validation.
• To determine if atypical depression is a distinct and valid clinical syndrome.

Main Methods:

• A comprehensive literature search was conducted for English language articles from 1969 to March 1996.
• Studies were selected based on primary research, a clear definition of atypical depression, and relevance to validation criteria.
• Selected studies were evaluated using Kendall's six criteria for establishing clinical validity.

Main Results:

• Supporting evidence for diagnostic validity was found in clinical description and differential treatment response.
• Atypical depression demonstrated a superior response to monoamine oxidase (MAO) inhibitors compared to tricyclic antidepressants.
• Limited support exists for validity criteria including pathophysiology, diagnostic rarity, course/outcome, and genetics.

Conclusions:

• Atypical depression is a useful diagnostic concept, particularly for predicting differential drug responses.
• Further research is necessary to conclusively demonstrate the validity of atypical depression as a distinct clinical syndrome.
• The current evidence supports its utility but calls for more rigorous investigation into its core features and biological underpinnings.